Nanomedicine: new hope for transplant paradigms lost?

Written by Nanomedicine

In this exclusive foreword, authors discuss the potential reformation of transplantation and regenerative surgeries that could result from the greater implementation of transplant nanomedicine over transplant immunosuppression. There has been tremendous interest, investment and progress in cancer nanomedicine over the past 2 decades. Nanomedicine approaches have facilitated safer, more effective and accurate tumor targeting at very low doses of drugs, prolonged half-life/activity and opened possibilities for combining diagnosis and therapy in one agent. Such ‘theranostic’ nanomedicine could help personalize chemotherapeutic delivery, monitor as well as optimize treatment adequacy or efficacy, and minimize toxicity to improve cancer survivability. In contrast to cancer nanomedicine,...

To view this content, please register now for access

It's completely free